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Magnetic Fields and Cancer: Animal and
Cellular Evidence-an Overview
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A few animal studies on the possible carcinogenic effect of magnetic fields have been published. They have been designed to reveal a possible
tumor promotion obtained by applying continuous or pulsed alternating fields at flux densities varying between 0.5 pT and 30 mT on mice or rats ini-
tiated with different initiators. One study with 2 mT applied on DMBA-nitiated mice may suggest a copromotive effect together with the promoter
TPA. Another study on rats suggests an inihibitory effect by a magnetic field on rat liver foci formation, induced with DENA. Cell studies show that
magnetic fields at some frequencies, amplitudes, and wave forms interact with biological systems. Thus effects have been seen, e.g., on enzymes
related to growth regulation, on calcium balance in the cell, on gene expression, and on pineal metabolism and its excretion of the oncostatic mela-
tonin. Cellular and physiologic studies thus suggest effects that may be related to cell multiplication and tumor promotion. - Environ Health
Perspect 103(Suppl 2):63-67 (1995)
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Introduction
Carcinogenesis is a multistep and multifac-
torial phenomenon (1). Early animal exper-
imental studies demonstrating the multi-
step character of tumorigenesis (2, 3)
defined the two major steps as initiation
and promotion by observing the develop-
ment of tumors in mouse skin after local
treatment with two types of carcinogens.
The term promotion was originally an
operational definition, associated with the
particular two-phase experimental protocol
used. Initiation has since been largely asso-
ciated with genotoxic effects due to direct
or indirect interactions between the car-
cinogen, or its metabolites, and DNA. The
promotion step is responsible for the con-
version of initiated cells to transformed
cells. Promotion is associated with a num-
ber ofcellular events, largely nongenotoxic
in nature. Some animal studies also form
the basis for a further division of the pro-
motion stage into stage I (conversion) and
stage II (propagation). Acontinuingcellular
evolution into a filly invasive and metasta-
sizing tumor cell tissue is termed progres-
sion. A chemical or physical factor capable
to be effective in all biological steps is
termed a complete carcinogen. It may be
possible in series of animal experiments to
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define the activity of a factor for one or
more ofthese (often overlapping) biological
steps. The multistep nature oftumor devel-
opment is assumed to be ageneral phenom-
enon and not restricted to certain tumors.
Two-phase experimental protocols
have been established for mouse skin
tumors and for rat liver tumors. In the
mouse, the occurrence of benign tumors,
papillomas, in the skin is analyzed and in
the rat the formation ofpreneoplastic cell
areas (foci) in the liver is determined.
Two-phase protocols for other types of
tumors, such as leukemia and brain
tumors, have been less commonly used in
animal models in the past. Such studies
with magnetic fields are planned or ongo-
ingwith different initiator regimens.
Animal studies are essential to define
the exposure parameters ofmagnetic fields
responsible for an effect. The flux density,
the frequency, the exposure duration, and
exposure profile are among the important
critical variables. Animal studies, as well as
cell studies, are also essential in order to get
an indication of the carcinogenic mecha-
nism. The identification of the carcino-
genic mechanism is important for a solid
riskassessment.
So far no full-scale, long-term animal
studies have been performed studying the
possibility of magnetic fields acting as a
complete carcinogen. Such studies are
planned or already started in the United
States (the NIEHS National Toxicology
Program) and Italy. Data from these stud-
ies will appearwithin the next fewyears.
In some animal experiments designed
primarily for studying possible tumor
promotion by magnetic fields (summarized
below), parallel series ofanimals have been
included, which attempt to give an indica-
tion on whether magnetic fields also act as
a complete carcinogen. As such parallel
series consisted generally of small group
numbers, only limited conclusions can be
drawn from those observations in this con-
text. With one exception (4), the other
studies (5,6) seem not to reveal an effect
of magnetic fields as a complete carcino-
gen. The Georgian study (4) showed
around 30% mammary tumors in rats
exposed to 20 IpT 50 Hz daily for lifetime.
Control animals had no tumors. Details of
design, exposure regimen, and tumor
observations are, however, lacking.
Animal Experiments
TumorPromotionStudies
In a 2-year tumor promotion study with
continuous 50-Hz magnetic fields, using
0.5-mT and 50-pT exposure on female
NMRI mice (5), the skin tumors and other
neoplastic lesions were observed after topi-
cal application of DMBA. The animals
were exposed to a magnetic field for 19 or
21 hr a day. TPA was used as a positive
control for skin tumor promotion. There
was no difference in skin tumor develop-
ment among DMBA and magnetic field-
exposed animals compared to the DMBA-
treated animals. This analysis was made
with correction for survival and made for
both cumulated tumor-bearing animals
and cumulated number of skin tumors.
Skin hyperplasia analyses did not reveal
skin hyperplasia among DMBA+magnetic
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field-exposed mice related to magnetic field
exposure.
A study (6) using female CBA/S mice
and pulsed magnetic fields at 20 kHz with
a saw-tooth shape and a flux density of
15pT (peak to peak) was designed to
observe a possible enhancing effect of X-
ray-induced lymphomas or ofspontaneous
lymphomas in this particular strain. Four
X-ray doses of 1.31 Gy each were adminis-
tered with a 4-day interval and the subse-
quent magnetic field exposure was per-
formed 24 hr/day over the lifetime. In the
X-ray-treated series a high lymphoma fre-
quencywas obtained. There was no statisti-
cal difference in lymphoma appearance
between the X-irradiated animals and those
also exposed to magnetic fields.
A large German study (7) using
Sprague-Dawley rats involved four experi-
ments and exposures to 15-mT DC fields
or a gradient field of0.31-1 pT, as well as
a homogeneous field of 30-mT (continu-
ous) 50-Hz AC fields, after initiation of
mammary tumors with repeated (4x5 mg)
oral administrations of DMBA. The expo-
sure was performed 24 hr/day for 91 days.
Magnetic fields did not alter the induced
tumor frequency except in one experiment,
where 30-mTAC fields increased the num-
ber of tumors per tumor-bearing animal.
Fifteen-millitesla DC fields increased
tumor weight but not tumor frequency in
one experiment. The number ofanimals in
the groups was small (18-36), limiting the
sensitivity of the study. Also, the exposure
and observation period was short. The
experiment with 30-mT AC fields was
repeated without the second time showing
an increase in the number of tumors per
tumor-bearing animal.
In a Georgian study (4) female rats
(strain not specified) were initiated with
NMU at a dose of 50 mg/kg bw adminis-
tered iv to induce mammary tumors,
which could be enhanced by subsequent
50 Hz magnetic field exposure. Two types
ofmagnetic fields were used, variable (AC)
fields and static (DC) fields with an inten-
sity of20 JT. The magnetic field exposure
was 0.5 hr or 3 hr daily starting 2 days
after NMU administration and possibly
ongoing for the animal's lifetime (exposure
details are not specified). Three hours of
daily exposure to AC or DC fields
increased the incidence of NMU-induced
mammary tumors, while 0.5 hr of daily
exposure did not. Also, the time-to-tumor
appearance was shorter among the animals
exposed for 3 hr daily. In the 3-hr groups,
malignant tumors dominated among the
histologic types, compared to the control
group. The results obtained in these experi-
mental series need to be confirmed.
The rat liver foci model has been used
in a series ofexperiments (8,9). The expo-
sure lasts for 12 weeks, when animals are
sacrificed and liver samples are taken for
staining for the enzyme markers, GSTp
and GGT. In one study (8), 0.5-, 5-, 50-
PT, and 0.5-mT continuous magnetic
fields at 50 Hz were used in a tumor pro-
motion protocol using Sprague-Dawley
rats and DENA as initiator. This study did
not show an enhancing effect of continu-
ous magnetic fields on the development of
preneoplastic foci induced by DENA.
Interacdon Studies
In three papers on skin tumor promotion
in SENCAR mice (10-12) 2 mT and 60
Hz continuous magnetic field-exposure
was used during 6 hr/day, 5 days/week up
to 21 to 23 weeks. In the investigation by
McLean et al. (11) both promotion
(above) and co-promotion of skin papillo-
mas were studied in female SENCAR mice
exposed to 2-mT, 60-Hz magnetic field.
Using an initiating treatment of 2.56 pg
DMBA (10 nmole) and a subsequent expo-
sure to 1 pg TPA applied to the dorsal skin
weekly, they tested whether a 21-week
magnetic field exposure could modify
tumor development. They found a slightly
earlier development of tumors in the mag-
netic field-exposed animals, the difference
in time to appearance oftumors was, how-
ever, not statistically significant. In a fol-
low-up study (12) the same strain and sex
was exposed under the same field condi-
tions using a weekly dose of 0.3 mg of
TPA. The rate of tumor development was
found to be increased in the magnetic
field-exposed group compared to a sham-
exposed TPA group. A difference in the
cumulated number of mice with tumors
was observed, but this difference did not
reach statistical significance at the end of
the observation period (23 weeks).
Splenomegaly (11) was observed among
the TPA+ magnetic field-exposed mice,
and there was a greater number of
mononuclear cells in the spleens ofanimals
with combined exposure. There was also a
depressed NK cell activity. This is sugges-
tive of a suppression of the immune sys-
tem, possibly related to a development of
leukemia/lymphomas.
In one liver foci experiment (9), 50-
Hz continuous magnetic field exposure at
0.5 pT and 0.5 mT was applied during
both the hepatectomy and the initiation
phase (with DENA), as well as during the
promotion phase in combination with a
phenobarbital (PB) treatment. The forma-
tion of preneoplastic foci was slightly
inhibited in terms of foci area, frequency,
and volume for both enzyme markers.
This inhibition was statistically significant
for 0.5 pT in terms of number of GGT-
positive foci per cubic centimeter liver and
for 0.5 mT in terms ofmean area and per-
centage foci volume as estimated by the
GSTp marker.
Hitherto published animal studies, using
continuous 50- or 60-Hz magnetic fields,
do not support the hypothesis of a tumor
promotive effect ofmagnetic fields, as stud-
ied in mice and rats, with different protocols
and initiators. Only one study reports a
(surprisingly) high incidence of mammary
tumors induced by NMU after 3 hr ofdaily
exposure to variable orstatic magnetic fields.
One other study in mice suggests a copro-
motional effect of 2-mT and 60-Hz mag-
netic fields obtained with the skin-specific
control promoter. The suggestive informa-
tion on mammary tumors and copromotion
of skin tumors needs to be confirmed.
Several animal experimental studies on
tumor promotion with different magnetic
field exposure regimens, initiators, tumor
types under observation, and animal strains
are ongoing or planned in Canada, Italy,
Japan, Sweden, and the United States.
PhysiologicStudies
One hypothesis, which has been forward-
ed (13) for magnetic field-related cancer
development, is derived from physiologic
studies on the hormone melatonin.
Melatonin is excreted nightly from the
pineal gland, and its formation and secre-
tion are inhibited by periods of light or
magnetic field exposure. Melatonin is
oncostatic (14) via inhibition ofthe mito-
genic activity of, e.g., estrogen, or by act-
ing directly by blocking cell proliferation
(15). Disturbances in the melatonin
rhythm appear also to affect the function
ofthe immune system (16). Pinealectomy
increases chemically induced melanomas
in Syrian hamsters (17) and mammary
tumors in the rat (14,18). Injections of
melatonin into rats induced with DMBA
reduced tumor growth and incidence in
some studies (18-21). Whether melatonin
plays a regulating role for the development
ofother tumor types is not known.
Short, repeated exposures to 40-pT
magnetic fields inhibit the conversion of
serotonin to melatonin in the pineal gland
in the rat (22), probably by eddy currents
(23,24) induced by rapid alterations in the
instantaneous inversion of the horizontal
component ofthe geomagnetic field.
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Cell Experiments
A few studies have been made on the pos-
sible genotoxicity of magnetic fields on
cell systems (25), without finding muta-
tions in Salmonella (26,27), strand breaks
(28), or effects on DNA repair in human
fibroblasts in vitro (29). In some of these
studies there have been exposures to both
electric and magnetic fields. Pulsed mag-
netic fields in some pulse widths, flux
densities, and frequencies, but not in oth-
ers, seem to increase the rate ofDNA syn-
thesis (30) of V79 cells and human
fibroblasts (31) in vitro.
There seems to be general agreement
(25,32,33) among reviewers on the issue of
possible DNA injury related to magnetic
field exposure that no such effects can be
ascribed to magnetic fields.
Studies with cellular systems using dif-
ferent exposure setups, exposure durations,
amplitudes, frequencies, and wave forms
indicate that biological effects of magnetic
fields on cellular systems are at hand
(34-44), which may be related to cell mul-
tiplication or even tumor promotion.
Exposing human leukemia cells
(45-47) or normal rat lymphocytes (48)
to electromagnetic fields at various fre-
quencies increases the transcripts of c-myc
or histone. Transcriptional changes on the
RNA level have also been observed with
magnetic field in Drosophila and Sciara
salivary gland cells (49,50) and in
Sacharomyces of specific genes, genes
responsible for the production of heat
shock proteins (51).
In addition to effects on c-myctranscrip-
tion, the expression ofc-fos, c-jun, and pro-
tein kinase C in a lymphoblastoid cell line
has been found to be altered by a magnetic
field exposure (52) ofshort duration and of
c-fos in a HeLa subline by a static magnetic
field (53). Those genes are involved in the
regulation of cell growth, and a change in
the production ofproteins resulting from a
changed expression of those genes may
influence the cellular proliferation in the tis-
sue. Should such cells already be initiated, a
tumor may result.
Effects on gene expression seem to
depend on frequency, field strength, and
exposure time (39,46). Thus the concept of
exposure or dose "windows," where biologi-
cal effects occur-like effects on calcium
metabolism (35,36,54), or increases in the
activity ofcertain enzymes (55) involved in
cell growth-has been forwarded.
It seems to be well established that elec-
tromagnetic fields induce changes in the cal-
cium metabolism ofexposed cells. The cal-
cium efflux has been increased (37, 54-57)
in a number ofstudies; also, an increase in
cytosolic calcium from extracellular sources
in stimulated rat thymocytes exposed to 60-
Hz sinusoidal magnetic field (44) and 3-
Hz pulsed fields has been observed (58).
Magnetic fields from an MRI unit (59)
increase cytosolic calcium in human
leukemia cells. Calcium is involved, e.g., in
cellular processes (signal transduction) lead-
ing to mitogenesis; and the investigation of
the magnetic field interaction with the calci-
um balance may be ofgreat importance for
the understanding of the molecular mecha-
nism of magnetic field effects on different
cell types. Transmembrane calcium signal-
ing events may also be of importance (57)
for the mediation of magnetic field effects
on cells ofthe immune system. The effect of
magnetic fields on calcium metabolism
seems to be optimized when the ratio ofthe
electromagnetic frequency to the DC field
intensity equals the charge-to-mass ratio
(cyclotrone resonance theory) ofnonhydrat-
ed ions such as calcium, lithium, potassium,
and magnesium (60).
The cell growth-related enzyme
ornithine decarboxylase has been found to
be increased (61) in mammalian tumor
cells after exposure to electromagnetic
fields. This increase was optimized (62) in
mouse fibroblasts when the coherence of
the time-varying magnetic field was main-
tained for a certain minimum period.
Exposure of mouse embryo cells in
vitro to repeated 60-Hz electromagnetic
fields enhances the colony formation of
TPA-treated cells (63). This suggests that
magnetic fields may act as a growth stimu-
lator via membrane-related events. Also,
studies using 72-Hz pulse trains and 15-Hz
recurrent bursts (64) on osteoblasts in
vitro indicate that magnetic fields affect
membrane receptor function as observed
by an inhibition of responses of cells to
parathyroid hormone.
Thus studies on a variety of cellular
systems, including mammalian and human
cells, seem to indicate that biological
effects on the cellular and subcellular level
can be related to electromagnetic fields.
The effects studied have some relevance to
cell function and growth and, perhaps,
tumor promotion. The exposure parame-
ters are far from well characterized or uni-
form over the cellular systems studied.
Furthermore, the possible magnetic field-
related effects on cellular and subcellular
phenomena need to be demonstrated as to
their validity for whole animals (41) at
long-term exposure conditions that can be
related to human risk.
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